santŽ ventures/headshots/casey

Casey Cunningham, MD Chief Scientific Officer

Casey Cunningham, MD is the Chief Scientific Officer of Santé Ventures. Dr. Cunningham received his fellowship training in oncology and hematology at Harvard Medical School, where he subsequently served on the faculty.  He was also one of the founding members of the Division of Experimental Medicine at the Brigham & Women’s Hospital in Boston, where he established a basic research laboratory in Cell and Molecular Biology.

He has over 70 publications in peer-reviewed journals and many abstracts and meeting presentations. Casey received his medical degree from the University of Texas Southwestern Medical School with a residency in Internal Medicine at the Medical College of Wisconsin. Casey returned to Texas in 1999 as the Associate Director of the Mary Crowley Cancer Research Center in Dallas, a position he held until 2007. He joined Santé Ventures shortly after its founding. He has served in operating roles in Terapio, Molecular Templates and Beta Cat Pharmaceuticals and has been, or is currently on, the Boards of Terapio Corp., Molecular Templates, Lyric Pharmaceuticals, AbVitro and Mirna Therapeutics.

News
June 16, 2017 Sentinel Cerebral Protection System Used Commercially by TAVR Centers of Excellence Nationwide
Read More
June 15, 2017 TVA Medical – Study Published In Prominent Journal Supports Use Of Innovative Endovascular Hemodialysis Access Technology
Read More